文献速递外周动脉疾病

多学科保肢治疗与大截肢患者死亡率降低及血运重建未增加相关

Multidisciplinary limb salvage care is associated with decreased mortality without increasing revascularization in major amputations.
PubMed 文献 · J Vasc Surg · 2025-04-12

研究纳入2014年1月1日至2021年12月31日单医疗系统内471例大截肢患者,比较多学科保肢团队(MLT)启动前后结局。MLT启动后30天、90天及1年截肢前血运重建率无显著差异,但30天截肢前清创/小截肢比例显著增加,大截肢总体及膝下截肢1年死亡率显著降低,膝上截肢1年死亡率无显著差异。

要点

  • MLT启动前后30天截肢前血运重建率分别为30.2%与30.6%,无显著差异(P=.93)。
  • MLT启动后30天截肢前清创/小截肢比例由25.9%升至44.9%,差异显著(P<.001)。
  • MLT启动后大截肢1年死亡率由26.4%降至14.3%(P=.002),膝下截肢由24.8%降至12.2%(P=.013)。

核心结论

  • 对于最终需行大截肢的慢性肢体威胁性缺血患者,实施保肢项目未改变截肢前血运重建实践,但与1年截肢后死亡率显著改善相关。
  • 作者认为研究结果进一步支持全球血管指南,证明保肢服务对大截肢患者有益。

研究设计与样本

  • 单医疗系统回顾性研究,通过电子病历中的现行操作术语代码识别2014年1月1日至2021年12月31日期间接受大截肢的患者,共471例。
  • 采用χ2检验、似然比检验、Mann-Whitney U检验和Student t检验比较MLT启动前后的患者变量与结局,并用单因素及多因素logistic回归分析相关因素。

主要发现

  • 471例大截肢中,膝下截肢占52%,膝上截肢占47%,经膝关节离断占1%。
  • MLT启动前后30天截肢前血运重建率分别为30.2%与30.6%(P=.93),90天分别为45.1%与45.8%(P=.87),1年分别为56.1%与51.9%(P=.84)。
  • MLT启动后30天截肢前清创/小截肢比例由25.9%升至44.9%(P<.001),90天和1年内同样显著增加。
  • MLT启动后大截肢总体1年死亡率由26.4%降至14.3%(P=.002),膝下截肢由24.8%降至12.2%(P=.013),膝上截肢由28%降至18.7%但无显著差异(P=.15)。
  • 与30天截肢前血运重建增加相关的因素包括高血压(OR 2.1,95%CI 1.2-3.8)、吸烟状态(OR 1.7,95%CI 1.1-2.6)及大截肢前30天内需清创/小截肢(OR 2.3,95%CI 1.4-3.6);年龄>65岁(OR 3.2,95%CI 1.6-6.3)和终末期肾病(OR 2.7,95%CI 1.5-4.9)与1年死亡率升高相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The development and implementation of a multidisciplinary limb salvage program has been shown to improve amputation-free survival and decrease need for major amputations; however, the impact of this approach on patients who eventually progress to major amputation is unclear. The goal of this study is to assess the effect of a multidisciplinary limb salvage team (MLT) on revascularization rates before major amputation and outcomes after major amputation in patients in an urban setting. METHODS: Patients in a single health care system who underwent major lower extremity amputations between January 1, 2014, and December 31, 2021, were identified using Current Procedural Terminology codes within our electronic medical records. Patient demographic data, comorbidities, pre-amputation revascularization, limb salvage procedures, and 1-year mortality rates were collected by chart review. The χ2 test, likelihood ratio tests, Mann-Whitney U test, and Student t test were used to compare patient variables and outcomes between before and after the launch of a MLT. Univariate and multivariate logistic regression analysis were used to assess patient characteristics associated with 30-day pre-amputation revascularization and one year mortality rates. RESULTS: During the study period, 471 patients underwent major lower extremity amputations: 52% below-knee amputations, 47% above-knee amputations, and 1% through knee disarticulation. Comparing preamputation revascularization procedures stratified by involvement of a multidisciplinary limb care team, there was no significant difference in 30-day revascularization rate (30.2% vs 30.6%; P = .93). Preamputation revascularization rates within 90 days (45.1%% vs 45.8%; P = .87) and 1 year (56.1% vs 51.9%; P = .84) remained similar between groups as well. There was a statistically significant increase in 30-day preamputation debridement/minor amputation (25.9% vs 44.9%; P < .001) after MLT implementation; this significant increase was also shown within 90 days and 1 year before major amputation. The 1-year mortality rate in above-knee amputations (28% vs 18.7%; P = .15) was not significantly different after MLT implementation, but 1-year mortality in the major amputations (26.4% vs 14.3%; P = .002) and below-knee amputations (24.8% vs 12.2%; P = .013) groups were significantly different after MLT implementation. Patient characteristics associated with increased 30-day pre-amputation revascularization included hypertension (odds ratio [OR], 2.1; 95% CI, 1.2-3.8), smoking status (OR, 1.7; 95% CI, 1.1-2.6), and requiring debridement/minor amputation within 30 days before major amputation (OR, 2.3; 95% CI, 1.4-3.6). Patients older than 65 (OR, 3.2; 95% CI, 1.6-6.3) with end-stage renal disease (OR, 2.7; 95% CI, 1.5-4.9) were associated with higher risk for 1-year mortality. Implementation of limb salvage program was associated with improved 1-year postamputation mortality overall (OR, 0.54; 95% CI, 0.31-0.96). CONCLUSIONS: For patients with chronic limb-threatening ischemia who eventually progressed to require major lower extremity amputations, the implementation of a limb salvage program did not change pre-amputation revascularization practice. However, it was associated with significantly improved 1-year postamputation mortality. Our findings further support the global vascular guidelines, demonstrating the benefit of limb salvage services in patients with major amputations.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kawaji Q, Martinson J, Husain S, et al. Multidisciplinary limb salvage care is associated with decreased mortality without increasing revascularization in major amputations. J Vasc Surg. 2025. PMID: 40222570. doi:10.1016/j.jvs.2025.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。